Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| InfuSystem Holdings, Inc | 25,000 | reported | 07 Sept 2017 | tx 4+112,900 |
| Esports Technologies, Inc. | 6,300 | reported | 09 Feb 2023 | tx 3+12,600−6,300 |
| CNS Pharmaceuticals, Inc. | 4,881 | reported | 17 Nov 2025 | tx 18+1,187,067−521 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Nov 2025 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 4,881 | 0.00 USD | deriv |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 40,000 | — | deriv |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 40,000 | — | deriv |
| 01 Feb 2024 | PURCHASE | CNS Pharmaceuticals, Inc. | 66,666 | 0.30 USD | |
| 01 Feb 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 66,666 | — | deriv |
| 01 Feb 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 66,666 | — | deriv |
| 22 Aug 2023 | PURCHASE | CNS Pharmaceuticals, Inc. | 27,000 | 1.27 USD | |
| 28 Apr 2023 | EXERCISE | CNS Pharmaceuticals, Inc. | 521 | — | |
| 28 Apr 2023 | EXERCISE | CNS Pharmaceuticals, Inc. | 521 | — | deriv |
| 17 Apr 2023 | PURCHASE | CNS Pharmaceuticals, Inc. | 3,100 | 3.20 USD | first after silence |
| 29 Mar 2023 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 6,067 | — | deriv |
| 09 Feb 2023 | EXERCISE | Esports Technologies, Inc. | 6,300 | — | |
| 09 Feb 2023 | EXERCISE | Esports Technologies, Inc. | 6,300 | — | deriv |
| 28 Apr 2022 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 250,000 | — | deriv |
| 11 Mar 2022 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 33,000 | 0.31 USD | |
| 09 Feb 2022 | GRANT_AWARD | Esports Technologies, Inc. | 6,300 | — | deriv |
| 06 Dec 2021 | PURCHASE | CNS Pharmaceuticals, Inc. | 5,000 | 0.94 USD | |
| 19 Nov 2021 | PURCHASE | CNS Pharmaceuticals, Inc. | 4,500 | 1.15 USD | first after silence |
| 05 Feb 2021 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 131,000 | — | deriv |
| 24 Aug 2020 | PURCHASE | CNS Pharmaceuticals, Inc. | 142,000 | 2.04 USD | first after silence |
| 13 Nov 2019 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 300,000 | — | deriv |
| 07 Sept 2017 | GRANT_AWARD | InfuSystem Holdings, Inc | 25,000 | 0.00 USD | deriv |
| 14 Aug 2017 | PURCHASE | InfuSystem Holdings, Inc | 7,900 | 1.90 USD | |
| 16 Mar 2017 | GRANT_AWARD | InfuSystem Holdings, Inc | 20,000 | 0.00 USD | deriv |
| 18 Aug 2016 | GRANT_AWARD | InfuSystem Holdings, Inc | 60,000 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 17 Apr 2023.